Equities

Vicarious Surgical Inc

RBOT:NYQ

Vicarious Surgical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.4223
  • Today's Change0.092 / 27.93%
  • Shares traded1.26m
  • 1 Year change-78.67%
  • Beta1.3654
Data delayed at least 15 minutes, as of May 18 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Vicarious Surgical Inc. is a robotics company, developing technology to improve surgical procedures. The Company is combining advanced miniaturized robotics, computer science, sensing and three-dimensional visualization to build a single-port surgical robot, called the Vicarious Surgical System, that helps surgeons to perform minimally invasive surgery. The Vicarious Surgical System is capable of incision sizes of approximately 1.2 centimeters. The Vicarious Surgical System consists of a camera and instrument arms, surgeon console and patient cart. The Vicarious Surgical System has a high-performance stereoscopic camera that, when combined with robotic motion, provides full 360-degree viewing capability and is being developed to continuously map the depth of the abdominal cavity. The Vicarious Surgical System surgeon console is designed to provide all the systems necessary for the surgeon in visualizing the surgical field and controlling all the motions of the robot.

  • Revenue in USD (TTM)0.00
  • Net income in USD-61.15m
  • Incorporated2021
  • Employees131.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
LivePerson Inc379.47m-118.65m64.91m1.10k--3.37--0.171-1.45-1.454.450.21710.4512--3.94346,548.80-14.11-15.03-20.78-19.7865.9667.25-31.27-32.03----0.9639---21.919.9855.51--2.25--
Mobile-Health Network Solutions7.87m-3.21m68.68m--------8.72-0.0945-0.09450.2316-0.0108----------------13.90---40.81--1.03------12.68---3,566.41------
authID Inc190.29k-19.62m69.84m22.00--5.29--367.00-2.77-2.730.02911.400.0154--1.088,649.55-158.30-121.38-179.39-146.17-----10,309.51-1,357.98---8.920.0167---63.92-45.1417.14---22.43--
Quantum Computing Inc358.05k-29.73m72.41m39.00--0.8379--202.23-0.4182-0.41820.0050.9460.0043--1.139,180.77-35.39-79.71-37.91-87.9845.36---8,303.50-26,197.810.673-16.510.033--163.95--22.96--213.36--
Arqit Quantum Inc640.00k-73.91m73.31m147.00--1.07--114.55-0.5621-0.53540.0050.40750.0057--0.11754,353.74-66.09---85.43-------11,548.13-----275.070.1119---91.13---238.38------
Dynastar Holdings Inc80.65k-43.72k73.51m1.00--306.71--911.52-0.0002-0.00010.00030.00011.53----80,650.00-83.09---152.63-------54.21------0.00---5.84--62.26------
Vicarious Surgical Inc0.00-61.15m74.34m131.00--0.8847-----0.3927-0.39270.000.47730.00----0.00-54.03---56.98--------------0.00-------1,478.15------
Katapult Holdings Inc221.59m-36.67m75.19m90.00----0.8370.3393-8.94-8.9454.21-6.871.92--88.642,462,089.00-31.76---52.93--18.82---16.55-12.38---1.061.48--5.77--9.40------
XBP Europe Holdings Inc0.00-22.20m76.32m-----------2.69-2.690.00-3.390.00-------112.71---238.25-------------0.158--------240.15------
Upland Software Inc291.53m-141.37m76.71m1.06k--3.87--0.2631-4.75-4.759.334.970.3389--7.37274,771.00-15.81-8.53-18.73-9.9568.4967.37-46.64-28.16---1.520.7738---6.1314.72-163.63--5.47--
Xiao-I Corp (ADR)59.17m-26.46m78.53m281.00------1.33-0.373-0.3730.84-0.06750.932347.231.61210,552.50-42.56---231.36--66.63---45.64--0.6588-9.761.33--22.79---348.62------
Forian Inc20.48m1.73m80.45m36.0066.883.1444.503.930.03980.33510.62750.84670.3896--4.82568,925.803.30-26.223.85-29.6573.2668.868.46-80.48----0.4872---26.8716.45106.67---13.46--
EUDA Health Holdings Ltd3.71m-8.44m81.85m106.00------22.08-0.3685-0.43840.1707-0.30450.2752--3.5534,966.61-62.62------22.72---227.57-----1.49-----1.54--66.17------
SilverSun Technologies Inc55.82m-1.21m81.86m195.00--10.76--1.47-0.2306-0.230610.581.432.66--17.18286,280.80-5.76-3.07-12.23-5.7939.2539.85-2.17-1.26--26.210.2022--21.195.86-279.17---30.83--
Cyber App cCorp313.20k-11.75m83.32m11.00------266.04-0.16-0.160.0042-0.12320.0364----28,472.73-136.51-----------3,750.77-----1.931.98--------------
Data as of May 18 2024. Currency figures normalised to Vicarious Surgical Inc's reporting currency: US Dollar USD

Institutional shareholders

18.87%Per cent of shares held by top holders
HolderShares% Held
MY.Alpha Management (HK) Advisors Ltd.as of 31 Dec 20237.38m4.73%
DDD Partners LLCas of 31 Mar 20246.89m4.42%
The Vanguard Group, Inc.as of 31 Mar 20244.37m2.80%
BlackRock Fund Advisorsas of 31 Mar 20243.87m2.48%
Comprehensive Financial Management LLC (California)as of 31 Dec 20232.07m1.33%
Geode Capital Management LLCas of 31 Dec 20231.37m0.88%
SSgA Funds Management, Inc.as of 31 Dec 20231.17m0.75%
Jacobs Levy Equity Management, Inc.as of 31 Dec 20231.07m0.68%
Renaissance Technologies LLCas of 31 Dec 2023685.75k0.44%
Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 2023587.20k0.38%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.